Publication | Closed Access
Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
172
Citations
26
References
2006
Year
Docetaxel/S-1 combination is highly active and well tolerated in advanced or recurrent gastric cancer. Further investigation in randomized studies is warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1